对急性ST段抬高型心肌梗死早期再灌注策略的再认识

被引:30
作者
韩雅玲
机构
[1] 沈阳军区总医院心内科
关键词
D O I
暂无
中图分类号
R542.22 [];
学科分类号
1002 ; 100201 ;
摘要
<正>心肌梗死是心血管病中最危急的疾病,具有很高的致死及致残率。实施有效的早期再灌注治疗,挽救濒死心肌是急性ST段抬高型心肌梗死(acuteST-segment elevation myocardial infarction,STEMI)治疗的关键环节。心肌梗死后2h,尤其是1 h以内,是再灌注的"黄金时间",如果能在这段时间内实现心肌水平的再灌注,挽救的心肌数量和生命数量是最多的,因此2h内达到再灌注是STEMI治疗的关键。在"黄金时间"每治疗1000例患者就可以挽救65个生命,而随着时间的延误,可以挽救的患者生
引用
收藏
页码:268 / 270
相关论文
共 6 条
[1]   中国ST段抬高的急性心肌梗死临床特征及治疗现状 [J].
杨艳敏 ;
朱俊 ;
谭慧琼 ;
梁岩 ;
章晏 ;
李建东 ;
刘力生 ;
CREATE中国课题组 .
中华医学杂志, 2005, (31) :2176-2182
[2]  
Door-to-balloon times for patients with ST-segment elevation myocardial infarction requiring interhospital transfer for primary percutaneous coronary intervention: A report from the National Cardiovascular Data Registry[J] . Tracy Y. Wang,Eric D. Peterson,Fang-Shu Ou,Brahmajee K. Nallamothu,John S. Rumsfeld,Matthew T. Roe.American Heart Journal . 2011 (1)
[3]  
1-Year Survival in a Randomized Trial of Facilitated Reperfusion[J] . Stephen G. Ellis,Michal Tendera,Mark A. de Belder,Ad J. van Boven,Petr Widimsky,Henning R. Andersen,Amadeo Betriu,Stefano Savonitto,Jerzy Adamus,Jan Z. Peruga,Maciej Hamankiewicz,Waladyslaw Pluta,Keith Oldroyd,Patrick Ecollan,Luc Janssens,Paul Armstrong,Bruce R. Brodie,Howard C. Herrmann,Gilles Montalescot,Franz-Josef Neumann,Mark B. Effron,Elliot S. Barnathan,Eric J. Topol.JACC: Cardiovascular Interventions . 2009 (10)
[4]  
2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)[J] . Frederick G. Kushner,Mary Hand,Sidney C. Smith,Spencer B. King,Jeffrey L. Anderson,Elliott M. Antman,Steven R. Bailey,Eric R. Bates,James C. Blankenship,Donald E. Casey,Lee A. Green,Judith S. Hochman,Alice K.
[5]  
Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial[J] . The Lancet . 2006 (9510)
[6]  
Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?[J] . Brahmajee K. Nallamothu,Eric R. Bates.The American Journal of Cardiology . 2003 (7)